























Inhibition of ionotropic GluR signaling preserves 
oligodendrocyte lineage and myelination in an ex vivo 
rat model of white matter ischemic injury
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Preterm infants have a high risk of neonatal white matter injury (WMI). WMI leads to reduced myelination, inflammation, and clinical 
neurodevelopmental deficits for which there are no effective treatments. Ionotropic glutamate receptor (iGluR) induced excitotoxicity 
contributes to oligodendrocyte (OL) lineage cell loss and demyelination in brain models of neonatal and adult WMI. Here, we hypothesized 
that simulated ischemia (oxygen‑glucose deprivation) damages white matter via activation of iGluR signaling, and that iGluR inhibition 
shortly after WMI could mitigate OL loss, enhance myelination, and suppress inflammation in an ex vivo cerebellar slice model of 
developing WMI. Inhibition of iGluR signaling by a combined block of AMPA and NMDA receptors, shortly after simulated ischemia, 
restored myelination, reduced apoptotic OLs, and enhanced OL precursor cell proliferation and maturation as well as upregulated 
expression of transcription factors regulating OL development and remyelination. Our findings demonstrate that iGluR inhibition 
post‑injury alleviates OL lineage cell loss and inflammation and promotes myelination upon developing WMI. The findings may help to 
develop therapeutic interventions for the WMI treatment.
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INTRODUCTION
Increasing evidence suggest that there are many 
factors potentially involved in the impaired brain de‑
velopment in preterm infants (Ogawa et al., 2020). 
Among these is the excitotoxic injury (Salter and Fern, 
2005; Fern and Matute, 2019; Ogawa et al., 2020). All 
these disturbances could lead to impaired oligoden‑
drocyte (OL) maturation, cell death, a loss of appro‑
priate myelination, and eventually – development of 
the condition named “white matter injury (WMI)” and 
neurological disorders. Since oligodendrogenesis and 
myelination takes place during the third trimester of 
the pregnancy and first year of postnatal life, ischemic 
WMI could result in exaggerated WM impairment in 
human children (Baltan et al., 2011). CNS myelination 
disturbance is a central feature in many conditions 
ranging from ischemia and cerebral palsy in infants to 
stroke and multiple sclerosis in adults (Matute, 2011). 
These resulting conditions can leave affected individ‑
uals severely handicapped with little or no recovery 
prospect, yet no specific pharmacotherapies presently 
exist (Fern and Matute, 2019).
Brain injury causes elevated glutamate levels in the 
extracellular space (Jensen, 2005; Beppu et al., 2014) 
largely due to the reversal of the glutamate transport‑
ers (GluT) (Stirling and Stys, 2010). Glutamate is re‑
leased via cystine‑glutamate anti‑porter activity and 
vesicular release after depletion of ATP ( Matute, 2011; 
Evonuk et al., 2020). High amounts of glutamate and 
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the resultant sustained activation of ionotropic gluta‑
mate receptors (iGluR) is implicated in subsequent OL 
and astrocyte death (Salter and Fern, 2005; Volpe, 2009; 
Canedo‑Antelo et al., 2018). In general, it is thought 
that responsible etiopathogenic mechanisms include 
glutamate excitotoxicity, elevated Ca2+ influx, oxida‑
tive stress, release of NO and pro‑apoptotic factors 
that stimulate caspases (Matute, 2011; Sanchez‑Gomez 
et al., 2003; 2011; Back and Rosenberg, 2014).
During development, the WM cellular elements 
are under attacks (Butt et al., 2014; Fern and Matute, 
2019). OL lineage cells are more susceptible to insults 
than other glial cells (Fern and Matute, 2019). OL lin‑
eage cells express Ca2+‑permeable iGluRs that make 
them susceptible to insults (Sanchez‑Gomez et al., 
2011; Fern and Matute, 2019). Injury to mature and 
immature OLs leads to myelination loss (Arai and Lo, 
2009). After insult, remyelination derives from OPC re‑
cruitment and differentiation (Li et al., 2015).
The OLs traverse several steps, from OPC that ex‑
press a set of markers such as PDGFαR and proteo‑
glycan NG2, to mature OLs that express myelin genes 
such as myelin‑associated glycoprotein (MAG), my‑
elin oligodendrocyte glycoprotein (MOG), myelin ba‑
sic protein (MBP), 2’‑3’‑cyclic nucleotide 3’ phospho‑
hydrolase (CNP), and proteolipid protein (PLP) (Mc‑
Tigue et al., 2001; Rivers et al., 2008). Regulation of 
the OL development is multifactorial, and many tran‑
scriptional factors including bHLH transcription fac‑
tors (e.g., Olig1, and Olig2) and a homeobox protein 
(e.g., Nkx2.2) play roles in the differentiation of OPCs 
as well as myelin regeneration (Fancy et al., 2004).
Therefore, pharmacological drug analysis enhancing 
myelin repair need to investigate of their impacts on 
OPC proliferation, expression of myelin genes, and 
transcriptional factors that regulate the development 
of OLs as well as re/myelination (Fern and Matute, 
2019). In this study, we hypothesized that WM isch‑
emia would activate iGluRs and that treatment with 
combined (AMPA and NMDA) iGluR block would min‑
imize population OL loss, reduce myelin disruption 




All animal experiments were carried out in accord 
with the regulations of the Research Ethics Committee 
of the Faculty of Biological Sciences at the University 
of Leeds and under the provisions of the UK Animals 
(Scientific Procedures) Act 1986.
Cerebellar ex vivo slice culture model
Methods were based on previously published proto‑
cols (Stoppini, 1991; Al‑Griw et al., 2021). Briefly, brains 
from 7‑day‑old Wistar rats (postnatal day 7) were used 
to generate cerebellar slice tissues that contained de‑
veloping WM. Pups were sacrificed, and the cerebellum 
was dissected and transversely sliced at a thickness of 
300‑µm on a vibratome (Leica, Germany). Eight to ten 
tissue slices per rat brain (at least 5 animals per each ex‑
perimental group) were carefully transferred onto hu‑
midified 1.0 µm pore size cell culture inserts (Millipore, 
Falcon, UK) and placed in a 6‑well plate (Falcon). The tis‑
sues were kept in one ml of serum‑based medium (50% 
minimum essential medium Eagle (MEME, Sigma), 25% 
HBSS (hanks balanced salt solution, Invitrogen), 20% 
normal horse serum (Invitrogen), 4.6 mM, (v/v) L‑gluta‑
mine (Sigma), 21 mM (v/v) D‑glucose (Fisher Scientific, 
UK), 1% penicillin/streptomycin solution (Invitrogen), 
4.2 µM (v/v) L‑ascorbic acid (Aldrich‑Sigma, Germany) 
and 11 mM (v/v) NaHCO3 at pH 7.2‑7.4) in a humidified 
aerobic incubator (5% CO2) at 37°C for 3 days.
Induction of white matter injury (WMI)
Ischemic WMI was simulated by exposing 7‑day‑old 
cultures to 20 min oxygen‑glucose deprivation (OGD) 
insult. Briefly, the tissue slices were transferred into fil‑
ter‑sterilized, deoxygenated glucose‑free culture medium 
for 20 min in an anaerobic airtight chamber with a mix‑
ture of 95% N2/ 5% CO2 gas flow, temperature maintained 
at 37±0.5°C. After OGD‑insult, the cultures were washed at 
least three times with fresh oxygenated culture medium 
containing 5 mg/ml D‑glucose and supplemented with 
0.3% B27 and returned to their culture conditions under 
normoxic atmosphere (5% CO2) at 37°C. Non‑OGD treated 
cultures (control cultures) were maintained for the same 
time under normoxic conditions. The cultures were incu‑
bated for 3 days before being fixed for analysis. 
Experimental group design
The tissue culture slices were randomly allocated to 
one of 3 groups. Group‑I (SHAM) tissue slices were cultured 
under normoxic conditions at 37±0.5°C at the time‑points 
corresponding to that in other experimental groups. 
Group‑II (WMI) tissue slices were cultured and subjected 
to 20 min of OGD insult in an atmospheric perfusion air‑
tight chamber (95% N2/ 5% CO2) gas flow at 37±0.5°C. Af‑
ter OGD treatment, the cultures were washed three times 
with normal medium before returning them to normoxic 
atmosphere for 3 days of reperfusion. Group‑III (WMI+‑
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blockers), cultured tissue slices were subjected to 20 min 
of OGD insult and then were treated with the blockers 
or vehicle alone (0.1% DMSO). All test pharmacological 
agents were added to culture medium 20 min before, 
during or 20 min after the OGD end and maintained in the 
culture medium for 60 min. Appropriate control groups 
were performed at the corresponding time‑points with 
these blockers to test their cytotoxicity. 
Drug application
To explore the role of N‑methyl‑D‑aspartate (NMDA) 
receptor, 10 µM of dizocilpine maleate MK‑801, an an‑
tagonist of the NMDA receptor, (dissolved in DMSO as 
10 mM stock; Tocris, Ellisville, UK) was used. Meman‑
tine (dissolved in DMSO as 5 mM stock; Tocris, Ellisville, 
UK) was also used to block NMDA iGluRs. α‑amino‑3‑hy‑
droxy‑5‑methylisoxazole‑4‑propionic acid (AMPA)/kain‑
ite GluRs were blocked using 30 µM of 2,3‑dihydroxy‑6‑ni‑
tro‑7‑sulfamoyl‑benzo(f)‑quinoxaline 2,3‑dione (NBQX, 
30 µM; Tocris, Ellisville, MO; dissolved in dissolved in 
DMSO as 30 mM stock). Nifedipine (Acros Organics, UK), 
a blocker of L‑type Ca2+ channels was dissolved in DMSO 
as 10 mM stock. The involvement of reversal GluTs in 
OGD‑induced damage, as important glutamate release 
source was tested using 200 µM of DL‑TBOA (Tocris El‑
liville, MO; dissolved as 100 mM stock in 100 mM NaOH 
stock). All drugs were stored at ‑20°C prior to use.
Glutamate assay
The released glutamate from cultured cerebellar slices 
into superfusate was measured using an enzymatic assay 
(glutamic acid/glutamate oxidase assay, Invitrogen, UK). 
In brief, 50 µl of diluted L‑glutamate‑containing sam‑
ples from each well was transferred to separate wells of 
a fluorescence microplate reader and mixed with 50 µl of 
100 µM Amplex®Red reagent containing 0.25 U/ml horse‑
radish peroxidase (HRP), 0.08 U/ml L‑glutamate oxidase, 
0.5 U/ml L‑glutamate‑pyruvate transaminase, and 200 µM 
L‑alanine at 37°C for 45 min. Optical densities were mea‑
sured using excitation at 530‑560 nm and emission detec‑
tion at 590 nm. Glutamate concentrations in experimental 
samples were calculated by comparison with a standard 
glutamate solution. 
Cell survival assay
Cell survival was measured using a Live/dead Viabili‑
ty/Cytotoxicity kit in accordance with manufacturer’s in‑
structions (Molecular Probes, Invitrogen, UK). Briefly, tis‑
sue slices were further incubated in the presence of a com‑
bined solution containing 4 µM ethidium homodimer‑AM 
(EthD‑1) and 2 µM calcein‑AM (Cal) at 37°C for 30‑45 min, 
and were then fixed in 4% paraformaldehyde (PFA, Sig‑
ma, UK) in phosphate‑buffered saline (PBS, Oxoid, UK) for 
30 min at room temperature. Using confocal microscopy, 
viable cells showed the green fluorescence of Cal and dead 
cells showed the red fluorescence of EthD‑1.
TUNEL assay
Apoptosis was identified at single cell level based on 
labeling of DNA strand breaks using TUNEL (terminal de‑
oxynucleotidyl transferase‑mediated dUTP digoxigenin 
nick‑end labeling OH ends in genomic DNA with Fluores‑
cein) detection kit in accordance with manufacturer’s 
recommendation (Chemicon, ApopTag Fluorescein in Situ 
Apoptosis Detection kit, UK). Briefly, tissue slices prepared 
and cultured as described above, were then fixed with 4% 
PFA in PBS for 30 min at room temperature. The fixed slices 
were incubated in working strength terminal deoxynucle‑
otidyl transferase (TDT) enzyme for 1 h at 37°C in the dark, 
and the reaction was stopped by stop/wash buffer. DAPI (4, 
6‑diamidino‑2‑phenylindole, Vector Laboratories, UK) was 
applied to stain nuclei. Non‑specific staining was examined 
by omission of the TDT in the labeling procedure. 
Cell proliferation studies
Cell proliferation was determined by using the DNA 
replication marker BrdU (5‑bromo‑2`‑deoxyuridine, Al‑
drich‑Sigma, UK). Cultured tissue slices were incubated in 
medium containing 20 µM BrdU for 3 or 24 h prior to fix‑
ation. The fixed cultures were incubated with 1N HCL for 
10 min on ice followed by 10 min incubation with 2N HCL 
at room temperature before placing them in an incubator 
at 37°C for 20 min. To neutralize acid, slices were incubat‑
ed with borate buffer (0.1 M, pH=8.5) for 12 min at room 
temperature, followed by three 5 min washes in PBS with 
1% Triton 100‑X. The slices were subsequently permea‑
bilized in a solution containing PBS (1M) with 1% Triton 
100‑X, glycine (1 M) and 5% normal goat serum for 1 h 
prior to incubation overnight with anti‑BrdU mono‑anti‑
body (eBioscience, UK) at a dilution 1:50 in PBS followed 
by DAPI labelling of nuclei. The proliferating (BrdU+/
DAPI+) cells were then counted.
Immunocytochemistry
For immunocytochemical analysis, the cultured 
slices were fixed in 4% PFA in PBS for 60 min at room 
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temperature. Following 3 washes with PBS; the slices 
were mounted on glass and were then blocked for 1 h 
at room temperature with a serum blocking solution 
(10% normal goat serum (MP Biomedical), 0.25% Tri‑
ton 100‑X (Sigma, UK) in PBS. Primary antibodies were 
diluted in PBS and were then incubated for 24 h at 4°C 
in the dark. The slices were washed 3 times for 5 min 
in PBS and secondary antibodies diluted in PBS were 
added for 2 h at room temperature in the dark fol‑
lowed by three washes in PBS. The sections were incu‑
bated with 100 µl of primary antibody (anti‑MBP; an‑
ti‑NG2, Millipore, and Anti‑NF200; Sigma) for 90 min 
at room temperature or overnight in dark at 4°C. The 
sections were then washed three times for 5 min in 
PBS, stained with secondary antibodies (Alexa Fluor® 
633 and 488) (Invitrogen, Germany), which were dilut‑
ed in PBS (1:1000), for two hours at room temperature 
in the dark, and then washed three times in PBS. DAPI 
was used for morphological assessment of nuclei. To 
determine the specificity of immunolabelling with 
the antibodies, control tissues were processed with‑
out primary antibodies, which resulted in no immu‑
nostaining.
Assessment of WM element injury
Imaging of immunostained slices was performed by 
inverted Zeiss LSM 510 Meta confocal laser scanning 
microscope with HeNe and argon lasers (Carl Zeiss, 
Inc., Germany) with confocal configuration 405 nm 
(DAPI, blue), 488 nm (FITC, green), 543nm (rhodamine, 
red), and 633 nm (cy5, red) fluorescence. 
To quantify myelination (myelin‑axon alignment), 
immunofluorescence double labeling of MBP (my‑
elin basic protein) protein, and its alignment with 
NF (neurofilament) protein was performed. A series 
of immunofluorescence images were gathered in the 
z‑axis from a confocal microscopic field in the mid‑
line of each tissue section using a 63X oil immersion 
objective lens. The confocal images were randomized 
and divided into a 5×5 grid. The images were scored by 
a blind observer. Percent of myelination of axons was 
measured across a minimum of 9 predetermined grid 
sections outlined by hand using imageJ. The length of 
each axon was measured based on NF‑staining, as was 
the length of the axon that showed colocalisation with 
MBP. The proportion of the axon showing colocalisa‑
tion with MBP was then calculated. The number from 
3 images were averaged and used as damage score of 
a single section.
Injury to OLs was evaluated by counting total 
number of MBP+ OLs as well as the percent of apop‑
tosis among OL population by a blinded observer to 
the experimental conditions as described previously 
(Mangin et al., 2012). Morphological characteristics 
of pyknotic OLs were also counted. Apoptosis among 
OL population were determined and counted based on 
morphological characteristics as previously described 
(Back et al., 2002).
Cell quantification pixel intensity measurement
Immunopositive cells were counted in 5 randomly 
selected fields per slice with 3 slices per animal per con‑
dition with at least 4 independent biological replicates 
under 63X magnifications using 9 predetermined grid 
sections outlined manually using ImageJ (National In‑
stitutes of Health, MA, http://rsb.info.nih.gov/ij/) with 
a grid size, 400 × 300 µm; counting frame, 25 × 25 µm; 
z‑depth 50 µm. 
Quantitative analysis of the immunoreaction inten‑
sity (pixel intensity) was performed in a series of con‑
focal immunofluorescence images (z‑depth 50 µm) at 
40× magnification (1024 × 1024 pixels) using ImageJ as 
previously described (Olivier et al., 2009).
Expression studies
RNAs were isolated from the cultured tissues us‑
ing TRIzol (Invitrogen, UK), and cDNA was synthesized 
with Super Script II reverse transcriptase (Invitrogen). 
Quantitative real‑time reverse transcriptase poly‑
merase chain reaction (Q‑RT‑PCR) was carried out with 
a Rotor Gene 6000 PCR analyzer (Corbett Research, UK) 
with primers described in Table 1. Specificity of PCR 
amplification and the absence of primer dimers were 
confirmed by analysis of cycling and melting curves. To 
further confirm appropriate amplification, the size of 
amplicons (PCR products) was verified on gel electro‑
phoresis and sequencing. Transcript levels were nor‑
malized to the housekeeping U6. 
Statistical analysis
Findings were analyzed using the SPSS version 20.0 
Statistical Package for Social Science (SPSS Inc., Chica‑
go, IL, USA). All data represent the mean±SEM for at 
least 5 independent experiments performed in tripli‑
cate. Normality was assessed using the computerized 
Kolmogorov‑Smirnov test. One way analysis of variance 
(ANOVA) followed by a post‑hoc test for multiple com‑
parisons Dunnett’s were used to determine statistical 
significance between the studied groups. P values<0.05 
were considered statistically significant.
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RESULTS
Ex vivo cerebellar slices model replicates 
ischemia‑induced WMI
To test the adequacy of ex vivo cerebellar slices 
model for investigation of ischemia‑induced WMI, glu‑
tamate release levels in cerebellar slice culture me‑
dium was measured. Baseline level of glutamate was 
measured for 20 min prior to OGD or inhibitor by sam‑
pling small volumes of cell supernatant from each well 
at serial time points. For comparison, data were nor‑
malized to the average glutamate levels of control slice 
cultures, which ranged from 60‑70 nM and remained 
constant under normoxia. The results show that gluta‑
mate release began a few minutes after the OGD‑insult 
(Fig. 1A), and peaked (10‑fold higher compared with 
basal levels) 20 min after WMI end (Fig. 1A). The data 
also showed that long‑term effects of OGD‑induced 
glutamate release can continue days after the insult 
(Fig. 1A). The increase in the levels of glutamate was 
significantly reduced in culture medium of OGD‑treat‑
ed slices treated with DL‑TBOA, an inhibitor of gluta‑
mate transporter (Fig. 1A‑C).
Inhibition of iGluR signaling enhances cell  
survival upon WMI 
Because of inhibition of AMPA and NMDA receptors 
alleviates Ca2+‑mediated excitotoxicity and cell death 
(Fern and Matute, 2019), we reasoned that inhibition of 
AMPA and/or NMDA receptors might enhance cell sur‑
vival of WM elements after injury. To this end, we mea‑
sured cell survival after OGD in cultures exposed to the 
iGluR blockers. We found that cell survival was lower in 
the WMI group compared to SHAM group and that iG‑
luR block preserved cell survival (Fig. 2B). Specifically, 
the protection induced by NBQX in combination with 
either MK‑801 or memantine was greater that observed 
with any single inhibitor used alone (Fig. 2B). 
Considering the practical need for an effective 
treatment following an ischemic attack and in order 
to elucidate the mechanism of this anti‑excitotoxic 
treatment, we tested the impacts of MK‑801+NBQX 
when added for a 60 min period beginning 20 min after 
WMI. A 20 min post‑injury treatment with MK‑801+N‑
BQX was not as effective as immediate treatment but 
resulted in a significant reduction in WM damage 
(Fig. 2C). 
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Table 1. Rat mRNA primer sequences used for Q‑RT‑PCR.
Gene Reverse primers (5`‑3`) Forward primers (5`‑3`) Amplicon Size Source
U6 aacgcttcacgaatttgcgt ctcgcttcggcagcaca 120 bp Eurogenetic
NG2 gctcacagaatattcccagca cagaggaggctttggtgaac 63 bp Sigma
MAG caggcgcttctcactctca tcctgtacagccccgaat 65 bp Sigma
MOG cacggcggcttcttcttggt gtctatcggcgagggaaaggt 121 bp Sigma
MBP tgtgcttggagtctgtcacc ccgcctcagaagacagtgat 96 bp Sigma
PLP ctgccagtctattgccttcc agcattccatgggagaacac 94 bp Sigma
CNP aaattctgtgactacgggaagg ccgtaagatctcctcaccaca 74 bp Sigma
Gap‑43 cgggcactttccttaggttt cggagactgcagaaagcag 76 bp Sigma
Olig1 tgggtttcggagtggaga gcgagcctgaaagacagaac 60 bp Sigma
Olig2 cccctcccaaataactcaaac gaaatggaataatcccgaactact 86 bp Sigma
Nkx2.2 tgtgctgtcgggtactggg cgggctgagaaaggtatgga 96 bp Sigma
BDGαR agaaaaaggttaaaacccacctaag cacacgccacgtacatcc 96 bp Sigma
SOX10 agactgactgagcgactgagc tgtcctcctcacccttcttg 91 bp Sigma
Cas‑1 cacaagaccaggcatattctttc tgctttctgctcttcaacacc 110 bp Sigma
Cas‑3 catgacccgtcccttgaa ccgacttcctgtatgcttactcta 70 bp Sigma
Cas‑8 tcacatcatagttcacgccagt agagcctgagggaaagatgtc 72 bp Sigma
Cas‑9 gagcatccatctgtgccata cgtggtggtcatcctctctc 81 bp Sigma
BDNF ccttttctggtttgcaatgag cgaggttggaacctaacagc 68 bp Sigma
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Inhibition of iGluR signaling reduced  
apoptosis upon WMI
We next asked whether treatment with MK‑801+N‑
BQX‑induced protection after WMI involved changes 
in apoptosis. To this end, TUNEL assay in combination 
with DAPI‑nuclei labelling was carried out. We found 
that apoptotic (TUNEL+) cells were more abundant in 
the WMI group compared to SHAM group (Fig. 3A), 
and that pre‑treatment with MK‑801+NBQX substan‑
tially reduced their density (Fig. 3B). Interestingly, 
post‑treatment with MK‑801+NBQX was also effective 
in enhancing cell survival after WMI (Fig. 3B). Taken 
together with the data presented in Fig. 2, these find‑
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Fig. 1. Time course analysis of glutamate release after WMI. (A) represents the corresponding levels of glutamate released in the culture medium of 
cerebellar slices. Glutamate levels were measured, and expressed as the percentage of control. (B) and (C) show levels of glutamate quantified at 20 min 
and 72 h in post‑OGD DL‑TBOA treatment. Data are presented as mean ± SEM of 8 to 10 tissue slices/animal at least 5 animals/ each experimental group. 
(*) indicates P<0.05, (**) indicates P<0.01, and (***) indicates P<0.001.
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ings indicate a consistent protection conferred by 
post‑injury treatment with MK‑801+NBQX and sug‑
gests a window of opportunity to attenuate WMI ther‑
apeutically. 
Prolonged activation of iGluR signaling can acti‑
vate caspases (Matute et al., 2006) and their activation 
is considered a commitment to apoptotic cell death 
(Nicholson et al., 1995; Cohen, 1997). To investigate 
the molecular pathway/s involved in WMI‑mediated 
apoptosis, we measured the expression of caspase‑9, 
caspase‑8, and caspase ‑3 by Q‑RT‑PCR. Gene expres‑
sion studies demonstrated that caspase‑9, caspase‑8, 
caspase ‑3 mRNA expression levels were upregu‑
lated (Fig. 3C‑E). This suggests that WMI‑induced, 
caspase‑mediated apoptosis, in this model, was via the 
iGluR signaling pathway. 
Inhibition of iGluR signaling restores OLs and 
myelination upon WMI
Because iGluR activation mediates OL death, inhib‑
its OPC maturation, and myelination in hypoxia‑isch‑
emia models (Volpe, 2009; Doyle et al., 2018; Fern and 
Matute, 2019), we reasoned that inhibition of iGluR sig‑
naling might protect OL development and myelination. 
To this end, we immunostained the cultured slice sec‑
tions with antibody to MBP. At 3 days post‑WMI, there 
was a 50% reduction in the average number of MBP+ 
OLs compared to SHAM group (Fig. 4A‑B), and that 
combined iGluR block (MK‑801+NBQX) enhanced the 
counts of MBP+ OLs (P=0.002, 103.91±8.96 cells per field; 
Fig. 4A‑B). Moreover, Q‑RT‑PCR results demonstrated 
that MAG, MOG, CNP, PLP, MBP, and GAP‑43 mRNA ex‑
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Fig. 2. MK‑801+NBQX treatment enhances cell survival after WMI. Cultured cerebellar slices were exposed to conditions of SHAM, WMI, or WMI+MK‑801+NBQX. 
(A) Representative immunofluorescence images of viable cells (green fluorescence of calcein‑AM, Cal) and dead cells (red fluorescence of ethidium 
homodimer‑AM, EthD‑1). Scale bar: 30 µm. (B) Quantification of viable cells. (C) Quantification of viable cells pre‑ and post‑treatment with MK‑801+NBQX 
after WMI. Data are presented as mean ± SEM of 8 to 10 tissue slices/animal at least 5 animals/ each experimental group. (*) indicates P<0.05 and (***) 
indicates P<0.001.
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pression levels were reduced in WMI group compared 
to SHAM group (Fig. 4C‑G), suggesting an ongoing my‑
elin disruption, and that MK‑801+NBQX treatment sig‑
nificantly upregulated MAG, MOG, CNP, PLP, and MBP 
expression, but not an axonal regeneration marker 
GAP‑43 in WMI group (Fig. 4C‑G). This is consistent 
with a high cell survival.
Next we asked whether MK‑801+NBQX treatment 
declined apoptosis among MBP+ OLs in this model. To 
this end, we double‑labeled the cultured slice sections 
for TUNEL and MBP antigen (Fig. 4H). We found that 
apoptotic MBP+ OLs were more abundant in the WMI 
group compared with SHAM group (Fig. 4I), and that 
MK‑801+NBQX treatment substantially reduced the 
density of apoptotic MBP+ OLs (Fig. 4I).
We next evaluated the impacts of blocking iGluR 
signaling on myelination after WMI. To this end, we 
determined at which day of ex vivo myelination (my‑
elin‑axon alignment) was high enough to reliably study 
the impacts of WMI on the status of myelination as 
a measure of WM damage. During rodent brain devel‑
opment, myelination is not easily detectable in the first 
postnatal week. However, at the second and third post‑
natal weeks, there is an increase expression in MBP and 
NF. We measured MBP and NF expression over time in 
our ex vivo model. We found that myelin‑axon alignment 
gradually increased from 6 to 7 days in culture, which 
is an equivalent in maturation stage to the human fe‑
tus. The impacts of WMI on the integrity of myelin‑ax‑
on colocalisation were therefore measured at 7 days 
in culture followed by 3‑days reperfusion (Fig. 5A). 
No MBP‑NF loss was seen in SHAM group (Fig. 5A‑B). 
The OL morphology conformed to prior descriptions, 
characterized by primary process running parallel to 
axons (Butt and Ransom, 1993; Salter and Fern, 2005). 
At 3 days post‑WMI, there was a marked decrease in the 
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Fig. 3. MK‑801+NBQX treatment minimizes delayed cell death after WMI. Cerebellar slices were cultured and exposed to conditions of SHAM, WMI, 
or WMI+MK‑801+NBQX. (A) Representative immunofluorescence images for TUNEL (green) and for DAPI‑labelled nuclei (blue). Sale bar: 20 µm. 
(B) Quantification of TUNEL+ cells. Relative mRNA expression levels for (C) caspase‑8, (D) caspase‑9, (E) caspase‑3. Data were normalized for the 
mean of the relative expression of to U6. Expression levels are presented relative to levels in SHAM group, where were set at 1. Data are presented 
as mean ± SEM of 8 to 10 tissue slices/animal., at least 5 animals/ each experimental group. (*) indicates P<0.05, (**) indicates P<0.01, and (***) 
indicates P<0.001.
Ionotropic GluR signaling in neonatal WMIActa Neurobiol Exp 2021, 81
myelin‑axon colocalisation (demyelination) compared 
to SHAM (Fig. 5A‑B), and that MK‑801+NBQX protected 
myelinated axons after WMI (Fig. 5A‑B). Together, these 
findings demonstrate that efficacy of iGluR blockers in 
preserving WM integrity after an ischemic injury. 
OL development and remyelination are modulated 
by key factors such as PDGFRα, Olig1, Olig2, Nkx2.2, 
Sox10 and NG2 (Fancy et al., 2011). Olig2 and Nkx2.2 are 
required for the expression of the major protein com‑
ponents of myelin; MBP, MAG, and PLP (Fu et al., 2002). 
Here we postulated that MK‑801+NBQX treatment 
might affect the expression of these factors. To this 
end, we measured PDGFαR, NG2, Olig2, Sox10, Nkx2.2, 
and Olig1 mRNA expression. We found that PDGFRα, 
NG2, Olig2, Sox10, Nkx2.2, and Olig1 expression were 
downregulated in WMI group compared to SHAM 
group, as measured by Q‑RT‑PCR, (Fig. 5C‑G). This low‑
er expression correlates with fewer numbers of OLs. On 
the other hand, MK‑801+NBQX treatment significant‑
ly upregulated PDGFRα, NG2, Olig2, Sox10, Nkx2.2, and 
Olig1 expression in WMI group (Fig. 5C‑G). Taken to‑
gether with the data presented in Fig. 4B, these results 
indicate that maintained the OL population which is 
reflected in more mRNA expressed OL cells.
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Fig. 4. MK‑801+NBQX treatment mitigates OLs after WMI. Cerebellar slices were cultured and exposed to conditions of SHAM, WMI, or WMI+MK‑801+NBQX. 
(A) Representative immunofluorescence images of MBP+ OLs (arrowheads, green). Scale bar: 20 µm. (B) Quantification of MBP+ OLs. Relative mRNA 
expression levels for (C) MBP and GAP‑43 and for myelin genes (D) MAG, (E) MOG, (F) CNP, and (G) PLP at 2 and 2 h after WMI. Data were normalized for 
the mean of the relative expression of U6. Expression levels are presented relative to levels seen in SHAM group, where were set at 1 (H) Representative 
images of TUNEL (green) and MBP immunostaining for OL (red). Scale bar: 20 µm. (I) Quantification of TUNEL+/MBP+ OLs. Data are presented as mean 
± SEM of 8 to 10 tissue slices/animal at least 5 animals/ each experimental group. (*) indicates P<0.05, (**) indicates P<0.01, and (***) indicates P<0.001.
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Inhibition of iGluRs enhances OPC survival  
and maturation upon WMI 
Here we investigated the impacts of iGluR inhibition 
on OPC survival in our ex vivo slice model of develop‑
ing WMI. To this end, we immunostained the cultured 
cerebellar slice sections with antibody to NG2, an early 
OPC marker. Under SHAM condition, there were a high 
number of NG2+ OPCs (Fig. 6A). The morphology of 
OPCs conformed to prior descriptions, characterized by 
small, irregular, rounded, cell bodies with a few short 
processes, highly branched (Levine and Card, 1987). At 
3 days post‑WMI, there was a roughly 60% reduction in 
the average number of NG2+ OPCs compared to SHAM 
group (Fig. 6A‑B), and that MK‑801+NBQX treatment 
enhanced the counts of NG2+ OPCs (Fig. 6A‑B).
To determine the role for apoptosis in regulat‑
ing NG2+ cell number, we double‑immunostained the 
cultured tissue sections for TUNEL and NG2 antigen 
(Fig. 6C). We found that apoptotic NG2+ OPCs were 
more abundant in the WMI group compared to SHAM 
group, and that MK‑801+NBQX treatment substantial‑
ly reduced the density of apoptotic NG2+ cells (Fig. 6D) 
suggesting that WMI promoted apoptosis among NG2+ 
OPCs.
Because MK‑801+NBQX treatment enhanced my‑
elination in our ex vivo model WMI, we postulated that 
MK‑801+NBQX treatment might also affect OPC prolif‑
eration. To evaluate OPC proliferation, we double‑im‑
munostained the cultured cerebellar slice sections for 
BrdU and NG2 antigen (Fig. 6E‑F). We found that pro‑
liferating NG2+ OPCs were less abundant in the WMI 
group compared to SHAM group, and that MK‑801+N‑
BQX treatment substantially increased their density 
(Fig. 6F).
In many models of injury‑induced myelination dis‑
turbances, myelin regeneration occurs due to OPC pro‑
liferation and differentiation (Suyama et al., 2007). To 
assess the impacts of the MK‑801+NBQX treatment on 
NG2+ OPC maturation, we used BrdU pulse‑chase ex‑
periment (Fig. 7A). After subjection to WMI condition, 
the cultured slices were exposed to a 3‑h BrdU pulse, 
and were then either fixed or maintained for a further 
3 days (Fig. 7A). Combined iGluR block (MK‑801+N‑
BQX) was applied 20 min after the end of OGD insult, 
and maintained for 60 min. The fixed cultures were 
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Fig.  5. MK‑801+NBQX treatment restores myelination after WMI. Cerebellar slices were cultured and exposed to conditions of SHAM, WMI, or 
WMI+MK‑801+NBQX. (A) Representative immunofluorescence images for MBP (green) and for NF (red). Arrowheads indicate demyelinated axons. Scale 
bar: 50 µm. (B) Quantification of myelinated axons from (%) Relative mRNA expression levels for (C) PDGFαR and NG2, (D) Olig2, (E) Sox10, (F) Nkx2.2, and 
(G) Olig1. Data were normalized for the mean of the relative expression of to U6. Expression levels are presented relative to levels seen in SHAM group, 
where were set at 1. Data are presented as mean ± SEM of 8 to 10 tissue slices/animal at least 5 animals/ each experimental group. (*) indicates P<0.05, 
(**) indicates P<0.01, and (***) indicates P<0.001.
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co‑stained for BrdU with NG2 antigen (Fig. 7B) or BrdU 
with MBP (Fig. 7C). After the 3 h pulse‑chase, incuba‑
tion with MK‑801+NBQX showed higher NG2+ OPCs with 
BrdU+ nuclei (Fig. 7D). However, there were no post‑mi‑
totic MBP+ OLs with BrdU+ nuclei following the 3‑h pulse 
(Fig. 7D). After the 3‑day chase period, the fraction of 
BrdU+ OPCs reduced and BrdU+/MBP+ emerged indicat‑
ing that these differentiated cells were derived from 
cells proliferating during the 3 h post‑OGD. MK‑801+N‑
BQX treatment enhanced the density of BrdU+/MBP+ 
OLs in the demyelinated cerebellar slices subjected to 
WMI condition (Fig. 7E). This suggests that MK‑801+N‑
BQX treatment restores OPC maturation in our ex vivo 
model of WMI.
Inhibition of iGluRs suppresses proinflammatory 
action upon WMI 
Her we asked whether combined iGluR block‑in‑
duced OL and myelin protection after WMI involved 
changes in the status of inflammation in our ex vivo rat 
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Fig. 6. MK‑801+NBQX treatment reduces apoptosis and promotes OPC proliferation after WMI. Cerebellar slices were cultured and exposed to conditions 
of SHAM, WMI, or WMI+MK‑801+NBQX. (A) Representative immunofluorescence images of NG2+ OPCs. Scale bar: 20 µm. (B) Quantification of NG2+ OPCs. 
(C) Representative immunofluorescence images for TUNEL (green) and for NG2 immunostaining for OPCs (red) Scale bar: 20 µm. (D) Quantification of 
TUNEL+/NG2+ OPCs. (E) Representative immunofluorescence images for BrdU (green) and for NG2 (red). Scale bar: 20 µm. (F) Quantification of BrdU+/NG2+ 
OPCs. Data are presented as mean ± SEM of 8 to 10 tissue slices/animal at least 5 animals/ each experimental group. (*) indicates P<0.05, (**) indicates 
P<0.01, and (***) indicates P<0.001.
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model of developing WMI. We found that a marked in‑
crease in the TNF‑α, IL‑6, IL‑1α, IL‑1β, and iNOS mRNA 
expression levels as revealed by Q‑RT‑PCR (Fig. 8). This 
finding correlates negatively with OL and OPC survival 
as show earlier (Fig. 5 and Fig. 6). More importantly, 
combined iGluR block was also effective in downregu‑
lating the TNF‑α, IL‑1β, and iNOS mRNA expression lev‑
els, but not IL‑6 and IL‑1α (Fig. 8). Because combined 
iGluR block suppresses proinflammatory action in WMI 
group, we reasoned that this might influence survival 
of OL lineage cells and myelination.
DISCUSSION
The novel findings in this work were that post‑treat‑
ment with combined iGluR block (MK‑801+NBQX) alle‑
viated WM pathology and inflammation. Specifically, 
combined iGluR block decreased OPC apoptosis, pro‑
moted OPC maturation, and enhanced remyelination in 
this model system of WMI. Our findings also demon‑
strate that combined iGluR inhibition after WMI pro‑
tects OL lineage cells and myelination, and downreg‑
ulation the mRNA expression of cytokines and iNOS. 
Hence, the current work highlights the role of iGluR 
signaling in WMI and suggests a neuroprotection strat‑
egy for neonatal WMI.
WMI takes place at several distinct sites including 
axons and OLs, microglia, and astrocytes. During isch‑
aemic injury, a plausible mechanism of excitoxicity is 
the reversal Na+‑dependent GluTs (Baltan et al., 2011; 
Butt et al., 2014; Fern and Matute, 2019). Astrocytes ex‑
press high levels of the Na+‑dependent GluT, and injury 
leads to dissipation of the transmembrane Na+ gradient 
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Fig.  7. MK‑801+NBQX treatment enhances OPC maturation after WMI. Cerebellar slices were cultured and exposed to conditions of SHAM, WMI, or 
WMI+MK‑801+NBQX. (A) Schematic of OPC maturation assay. (B) Representative immunofluorescence images of DNA replication marker BrdU (green) and 
OPC marker NG2 (red). (C) Representatives immunofluorescence images for BrdU (red) and for MBP (green) demonstrated that new mature myelinating 
MBP+ OLs (arrow) are present 3 days after injury in the slices treated with MK‑801+NBQX, but not all BrdU+ cells undergo OL differentiation. Scale bar: 
40 µm. (D) Quantification of BrdU+ NG2+ OPCs at 3 and 72 h after WMI. (E) Quantification of BrdU+/MBP+ OLs at 3 and 72 h after WMI. ND: not detected. 
Data are presented as mean ± SEM for at least 5 independent biological replicates. (*) indicates P<0.05 and (***) indicates P<0.001.
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in astrocytes (Fern and Matute, 2019) setting up condi‑
tions for reverse exchange as well as glutamate release 
(Baltan et al., 2011; Butt et al., 2014). In the present 
study, we found that WMI induced a high amount of 
glutamate release at early and late time periods after 
the end of OGD insult and that Na+‑dependent GluT‑in‑
hibitor DL‑TBOA treatment reduced its release. Excess 
glutamate activates iGluR causing iGluR‑mediated ex‑
citotoxicity, a crucial mediator of the damage develop‑
ing WM (Follett et al., 2004). Glutamate excitotoxicity 
leading to degeneration of motor neurons, mitochon‑
drial dysfunction, oxidative stress, inflammation and 
apoptosis (Corona et al., 2007). Blocking AMPA/kainate 
receptors alone during ischemia did not preserves axon 
potentials in myelinated optic nerve, and a similar lack 
of improvement was observed when NMDA GluRs were 
blocked alone (Bakiri et al., 2008). Our findings suggest 
that that inhibition of AMPA, kainate, and NMDA iG‑
luRs together is more protective against consequences 
of ischemic insult, suggesting that clinical application 
of NMDA GluR antagonists to treat developing WMI 
would require companioning it with AMPA/kainate 
antagonists. 
The occurrence of ischemic episode is unpredict‑
able, often making pre‑treatment not feasible. The 
efficiency of iGluR blockers as a post‑treatment strat‑
egy for developing WM ischemia, however, is still un‑
clear. In the present study, we found that post‑treat‑
ment with combined iGluR block (MK‑801+NBQX) to 
a time point shortly (20 min) after WMI resulted in 
a significant decrease in WM damage, suggesting per‑
sistent activation of iGluR signaling by extracellular 
glutamate after the end of OGD‑insult. The findings 
described above demonstrate that although pre‑treat‑
ment with MK‑801+NBQX before ischemic insult was 
the most effective, the consistent protection conferred 
by post‑injury treatment with combined iGluR block 
suggests a window of opportunity to attenuate WMI at 
birth. Because ischemic episodes are often associated 
with premature infants and these infants are generally 
maintained in a constantly monitored neonatal inten‑
sive care unit, commencing treatment even within few 
minutes’ post‑insults is feasible. 
One key question about WMI is the route by which 
cell death is triggered, and accordingly, which of sig‑
naling pathways could be chosen as a therapeutic tar‑
get. The expression of anti‑apoptotic gene BCL‑2 and 
neurotrophin BDNF are implicated in the cell death 
regulation (Hardingham et al., 2002; Hwang and Chun, 
2012). For example, BCL‑2 plays a crucial role in the 
cell death control through the stabilization of the mi‑
tochondrial membrane potential., thereby preventing 
release of cytochrome c and APAF‑1 in the cytosol, 
which recruits pro‑apoptotic pathways (Shimizu et 
al., 1999; Andrabi et al., 2019). In the present study, we 
found that WMI led to upregulation of caspase‑8, ‑1, ‑9, 
and ‑3 expression compared to SHAM group, and that 
treatment with MK‑801+NBQX post‑WMI modulated 
their expression. This suggests that reducing caspase 
expression may be a mechanism by which combined 
iGluR block confers protection against ischemia in‑
duced WMI. 
The WM elements are separately under ischemic 
attack. Overactivation of iGluRs plays a crucial role in 
mediating Ca2+‑dependent injury of OL populations and 
myelin with a subsequent axonal degeneration (Salt‑
er and Fern, 2005; Stys and Lipton, 2007). Given that 
presence of AMPA, kainate, and NMDA iGluRs on all WM 
compartments (Dohare et al., 2016; Fern and Matute, 
2019; Salter and Fern, 2005; Stys and Lipton, 2007), we, 
however, investigated whether the inhibition of iGluR 
would attenuate WM elements in our ex vivo model and 
OL cultures (Deng, 2010), as well as in acute tissue cul‑
tures (Salter and Fern, 2005). A study using rat optic 
nerve to model WMI, to study the early OGD effects 
found that iGluR blockers were effective against acute 
ischemic injury to OL populations (Salter and Fern, 
2005). These blockers were also effective when exam‑
ined 24 h after ischemia induced injury to neurons in 
hippocampus OSCs (Pringle et al., 1997). In a rat model 
of PVL, blockers of iGluRs were also effective in atten‑
uating WMI. Using an ex vivo model of WMI, we found 
that post‑treatment with MK‑801+NBQX significantly 
mitigates OL loss, a consequence of WM ischemia and 
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Fig. 8. MK‑801+NBQX treatment suppresses proinflammatory action after 
WMI. Cultured cerebellar slices were exposed to conditions of SHAM, WMI, 
or WMI+MK‑801+NBQX. Relative mRNA expression for TNF‑α, IL‑6, IL‑1α, 
IL‑1β, and iNOS at 20 min post‑insult. Data were normalized for the mean 
of the relative expression of to U6. Expression levels are presented relative 
to levels seen in SHAM group, where were set at 1. Data are presented as 
mean ± SEM for at least 5 independent biological replicates. (*) indicates 
P<0.05 and (***) indicates P<0.001.
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ischemia related CNS disorders seen in premature in‑
fants. Gene and protein expression studies demon‑
strate that combined iGluR inhibition with MK‑801+N‑
BQX protected myelin profile and transcription factors 
that regulating OL development and remyelination 
when administrated after OGD insult. 
Remyelination after injury‑induced demyelination 
is thought to depend – at least in part – on the OPC 
recruitment (Rivers et al., 2008; Li et al., 2015). Ex vivo 
brain models have been repeatedly employed to study 
remyelination after injury induced demyelination 
(Birgbauer et al., 2004; Harrer et al., 2009). Prior stud‑
ies (Harrer et al., 2009; Yang et al., 2011) showed that 
OPCs can proliferate and then differentiate into ma‑
ture forms within 3 days in brain slice system. In the 
present study, we found that MK‑801+NBQX treatment 
protected mitotic behavior of NG2+ OPCs in response to 
WMI. This observation raises the question whether it 
also enhances OPC differentiation after WMI induces 
demyelination. Using BrdU immunostaining, we found 
that treatment with combined iGluR block after injury 
enhanced NG2+ OPC differentiation into MBP+ OLs. The 
fact that iGluR blockers preserved OPC mitotic behav‑
ior, increased the number of new OLs (BrdU+/MBP+ OLs), 
and increased percentage of MBP+ membranes on NF+ 
axons in this model, supports our idea that the iGluR 
inhibition may impose a milieu favoring OPC recruit‑
ment and differentiation. 
Another major finding in this study is how inflam‑
matory response contributes to the deleterious im‑
pacts of ischemic insult on WM elements, including OL 
death and myelin disruption in the context of WMI. OL 
destruction resulting in demyelination is a central fea‑
ture of a number of human demyelinating disorders, 
including multiple sclerosis and cerebral palsy (Comp‑
ston and Coles, 2008). In demyelinating diseases, there 
are many overlapping cell death mechanisms of OLs. 
Myelination disturbances can occur due to apoptotic 
cascade activation induced by cytokines or due to their 
susceptibility to excitotoxicity. Microglia and astrocyte 
recruitment is a hallmark of the inflammatory response 
to hypoxia‑ischemia (Deng, 2010; Murugan et al., 2011). 
After injury, microglia and astrocyte activation is ac‑
companied by the releasing of massive proinflamma‑
tory mediators including reactive oxygen species (ROS) 
and cytokines (Deng et al., 2008; Murugan et al., 2011). 
Importantly, microglia express iGluR receptors; and ac‑
tivation of their iGluRs triggers release of TNF‑α and 
IL‑1β in conditions of brain injury (Noda et al., 2000; 
Takahashi et al., 2003; Kong et al., 2019). Additionally, 
astrocytes after injury were noted to increase release 
of pro‑inflammatory cytokines, such as TNF‑α and IL‑6 
as well as intercellular iNOS, NO, and ROS (Zhang et al., 
2018). Production of ROS triggers inflammation and 
apoptosis (Dirnagl et al., 1999; Khatri et al., 2018). Evi‑
dence indicates that cytokines (e.g., TNF‑α and IL‑1β), 
ROS (e.g., NO), and iNOS are toxic to OL lineage cells 
and myelin and interfere with OPC proliferation (Deng 
et al., 2008; Murugan et al., 2011; Wu et al., 2010; Yu et 
al., 2020).
Cytokines (TNF‑α and IL‑1β) injures OLs and delays 
myelination through binding to their respective re‑
ceptors on the OLs (Deng et al., 2008). OL loss and de‑
myelination are also thought to result from collater‑
al damage from iNOS in microglia (Yu et al., 2020) via 
NO production (Murugan et al., 2011). ROS, such as NO 
can react with superoxide anions to form peroxynitrite 
that can oxidize essential molecules such as DNA, lead‑
ing to cellular damage (Zhou et al., 2019). In this study, 
we found that ischemia induced an exaggerated release 
of glutamate which causes WMI. Binding of glutamate 
to its receptors can promote a further elevation in Ca2+ 
entry (Matute, 2011). Indeed Ca2+ overload upon acti‑
vation of these receptors can activate multiple puta‑
tive damaging proteins, such as iNOS. NMDA‑inhibitor 
MK‑801 alone was previously reported to downregulate 
ischaemia induced iNOS, NO, and cytokine production 
(Murugan et al., 2011; Park et al., 2016). In the pres‑
ent study, we found that combined iGluR block upon 
WMI suppressed inflammation. Specifically, we found 
that combined iGluR block decreased apoptosis among 
OPCs and releasing of cytokines and iNOS. Collectively, 
these findings could in fact suggest that iGluR activa‑
tion contributed to OL death and upregulated cytokine 
and iNOS expression; and MK‑801+NBQX treatment 
seemingly alleviated inflammation, decreased cytokine 
and iNOS, and consequently preserved OPC survival., 
proliferation, and maturation.
CONCLUSION
In conclusion, we highlight the potential therapeu‑
tic values of iGluR inhibition in specifically in pervert‑
ing or reversing ischemic WM pathology associated 
with a number of many neurological deficits. Addition‑
ally, our findings reinforce the linkage between inflam‑
mation and demyelination. The occurrence of ischemic 
episode is unpredictable, making pre‑treatment not 
possible. The efficiency and effectiveness of combined 
iGluR block MK‑801+NBQX as a post‑treatment strategy 
for developing WM ischemia, however, is still unclear. 
The findings of this study showed that delaying treat‑
ment with combined iGluR block to a time point shortly 
(20 min) after ischemia preserved WM elements, sug‑
gesting persistent of iGluR signaling by extracellular 
glutamate after the end of ischemic‑insult. Because 
newborn infants are generally maintained in a con‑
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stantly monitored neonatal intensive care unit, iGluR 
inhibition even within few minutes’ post‑insults is fea‑
sible to at least minimize WM damage.
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